Abstract
Serum IGF1 Is a Prognostic Marker for Resistance to Targeted Therapies and a Predictive Marker for Anti-IGF1 Receptor Therapy in Melanoma
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have